NIH-funded research R01 grant

Genetic factors in virus-related biliary atresia in children

Official title: Genetic basis of virus induced Biliary Atresia

Funded at Stanford University · NIH-11471608 · Data updated 2026-11-12

A study to understand how viral infections may trigger biliary atresia in very young children and how genetics influence this process.

More Biliary Atresia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startApril 1, 2011
Project endJanuary 31, 2029
Funding year2026
Award (this year)$633,850
NIH project number7R01DK091566-11
Project IDNIH-11471608 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children affected by biliary atresia or infants at risk due to perinatal viral exposure, whose condition could be studied through animal and cellular models and, in the future, potential clinical trials.

Less likely to help

This project is primarily preclinical; direct patient benefit may come from later translation and therapies.

What this research studies

This project uses specially modified rotavirus strains to model how infection can cause bile duct blockage and liver scarring in newborns. Researchers will examine how infected bile duct cells change the immune response and attract monocytes and macrophages, which contribute to fibrosis. By comparing the new viral models to traditional models, the team aims to pinpoint steps in the disease pathway that could be targeted for future treatments. The work is designed to shed light on why some children develop severe liver disease after a perinatal viral infection.

Why it matters

Potential benefit: Better understanding of how biliary atresia develops could lead to earlier interventions and new treatments to prevent liver damage in affected children.

How similar studies have gone: Previous animal models have helped validate viral involvement; this project introduces novel virus strains that may better reflect human disease.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Tiao, Gregory M — Stanford University
  • Study coordinator: Tiao, Gregory M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.